Literature DB >> 15579021

HIF-1alpha and p53 as targets of NO in affecting cell proliferation, death and adaptation.

Jie Zhou1, Tobias Schmid, Bernhard Brüne.   

Abstract

During the past years nitric oxide (NO) signaling became an integral component in understanding physiological and pathophysiological processes of cell proliferation, death or cellular adaptation. Among other activities NO affects multiple targets that allow regulation of gene expression. Although there is no evidence for direct NO-responsive DNA elements within promotor regions of eukaryotic genes numerous indirect signaling pathways exist to explain NO-regulated gene expression. A characteristic feature of some transcription factors such as hypoxia inducible factor-1alpha (HIF-1alpha) or p53 (tumor suppressor p53) is their low protein abundance in unstressed cells due to efficient 26S proteasomal degradation of the protein. Characteristically, the protein amount of HIF-1alpha or p53 is increased steeply upon hypoxic stress or mechanisms that require activation of "guardian of the genome", i.e. p53. Current available data illustrate that NO is endowed with the ability to mimic a hypoxic response by stabilizing HIF-1alpha and/or to accumulate p53 and thus to affect viability decisions. Here we review recent advances in understanding molecular mechanisms how NO affects stability regulation of HIF-1alpha and p53. Moreover, we summarize existing concepts how HIF-1alpha and p53 interact to direct proliferation, death or adaptation. Considering HIF-1alpha and p53 as targets of reactive nitrogen intermediates (RNI) may provide insights into basic chemical reactions, biochemical signal transduction pathways with broad implications for medicine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579021     DOI: 10.2174/1566524043359926

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  17 in total

Review 1.  Nitric oxide and cancer therapy: the emperor has NO clothes.

Authors:  Jason R Hickok; Douglas D Thomas
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

Review 2.  Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathways.

Authors:  Robert Y S Cheng; Debashree Basudhar; Lisa A Ridnour; Julie L Heinecke; Aparna H Kesarwala; Sharon Glynn; Christopher H Switzer; Stefan Ambs; Katrina M Miranda; David A Wink
Journal:  Nitric Oxide       Date:  2014-08-19       Impact factor: 4.427

3.  Importance of culturing primary lymphocytes at physiological oxygen levels.

Authors:  Kondala R Atkuri; Leonard A Herzenberg; Anna-Kaisa Niemi; Tina Cowan; Leonore A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

4.  Long-term adaptation of breast tumor cell lines to high concentrations of nitric oxide.

Authors:  Benjamin J Vesper; Kim M Elseth; Gabor Tarjan; G Kenneth Haines; James A Radosevich
Journal:  Tumour Biol       Date:  2010-05-18

5.  Hypoxia downregulates p53 but induces apoptosis and enhances expression of BAD in cultures of human syncytiotrophoblasts.

Authors:  Baosheng Chen; Mark S Longtine; Yoel Sadovsky; D Michael Nelson
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-01       Impact factor: 4.249

6.  The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress.

Authors:  Frank Staib; Ana I Robles; Lyuba Varticovski; Xin W Wang; Barry R Zeeberg; Michail Sirotin; Victor B Zhurkin; Lorne J Hofseth; S Perwez Hussain; John N Weinstein; Peter R Galle; Curtis C Harris
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

7.  Hypoxia-regulated retinal glial cell-specific promoter for potential gene therapy in disease.

Authors:  Howard M Prentice; Manas R Biswal; C Kathleen Dorey; Janet C Blanks
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-01       Impact factor: 4.799

8.  Part II. Initial molecular and cellular characterization of high nitric oxide-adapted human tongue squamous cell carcinoma cell lines.

Authors:  Gabor Tarjan; G Kenneth Haines; Benjamin J Vesper; Jiaping Xue; Michael B Altman; Yaroslav R Yarmolyuk; Huma Khurram; Kim M Elseth; John C Roeske; Bulent Aydogan; James A Radosevich
Journal:  Tumour Biol       Date:  2010-10-21

9.  Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension.

Authors:  Ziyi Wang; Kai Yang; Qiuyu Zheng; Chenting Zhang; Haiyang Tang; Aleksandra Babicheva; Qian Jiang; Meichan Li; Yuqin Chen; Shane G Carr; Kang Wu; Qian Zhang; Angela Balistrieri; Christina Wang; Shanshan Song; Ramon J Ayon; Ankit A Desai; Stephen M Black; Joe G N Garcia; Ayako Makino; Jason X-J Yuan; Wenju Lu; Jian Wang
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-10-25       Impact factor: 5.464

10.  Molecular mechanisms for discrete nitric oxide levels in cancer.

Authors:  Lisa A Ridnour; Douglas D Thomas; Christopher Switzer; Wilmarie Flores-Santana; Jeffrey S Isenberg; Stefan Ambs; David D Roberts; David A Wink
Journal:  Nitric Oxide       Date:  2008-04-22       Impact factor: 4.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.